Company Filing History:
1 out of 4 
1 out of 5 Years Active: 2020
Title: Innovator Spotlight: Katarzyna Kucwaj-Brysz
Introduction: Katarzyna Kucwaj-Brysz is a notable inventor based in Cracow, Poland, recognized for her significant contributions to the field of biomedical innovations. With a focus on developing compounds that target specific kinases, her work aims to advance therapeutic options in medical science.
Latest Patents: Katarzyna holds a patent for "Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases." The invention encompasses a compound of specified formula (I) alongside its salts, stereoisomers, tautomers, and N-oxides. Importantly, this innovation is intended for use as a medicament and as part of a pharmaceutical composition, highlighting its potential impact on healthcare.
Career Highlights: Throughout her career, Katarzyna has made significant strides within the pharmaceutical industry. She has worked with prominent companies such as Felicitex Therapeutics and Selvita, where her expertise has contributed to various successful projects focused on drug development and innovation.
Collaborations: Katarzyna has collaborated with esteemed professionals in her field, including Agnieszka Dreas and Charles-Henry Fabritius. These collaborations underscore the importance of teamwork in advancing research and innovation within the highly competitive landscape of biotechnology.
Conclusion: Katarzyna Kucwaj-Brysz stands out as an influential figure in the realm of biomedicine. Her patent and collaborations exemplify her commitment to innovation and her role in shaping future therapeutic advancements.